Sulfonylurea drugs in the treatment of diabetes mellitus. 1959

P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
January 1969, Dapim refuiim. Folia medica,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
April 1979, Comprehensive therapy,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
May 1980, Metabolism: clinical and experimental,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
January 1986, Harefuah,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
March 1999, Nihon rinsho. Japanese journal of clinical medicine,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
January 1973, La Prensa medica mexicana,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
February 1973, Metabolism: clinical and experimental,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
May 1979, Zeitschrift fur arztliche Fortbildung,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
July 1969, Arzneimittel-Forschung,
P B LANDABURE, and C DELBUE, and G ALVARINAS, and N SERANTES, and R C DAVALOS, and G WAISMAN, and A CABARROU, and E DUSSEL, and F CICCHITTI, and A LOREDO
April 2009, Clinical therapeutics,
Copied contents to your clipboard!